HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

The alternative oxidase AOX does not rescue the phenotype of tko25t mutant flies.

Abstract
A point mutation [technical knockout(25t) (tko(25t))] in the Drosophila gene coding for mitoribosomal protein S12 generates a phenotype of developmental delay and bang sensitivity. tko(25t) has been intensively studied as an animal model for human mitochondrial diseases associated with deficiency of mitochondrial protein synthesis and consequent multiple respiratory chain defects. Transgenic expression in Drosophila of the alternative oxidase (AOX) derived from Ciona intestinalis has previously been shown to mitigate the toxicity of respiratory chain inhibitors and to rescue mutant and knockdown phenotypes associated with cytochrome oxidase deficiency. We therefore tested whether AOX expression could compensate the mutant phenotype of tko(25t) using the GeneSwitch system to activate expression at different times in development. The developmental delay of tko(25t) was not mitigated by expression of AOX throughout development. AOX expression for 1 d after eclosion, or continuously throughout development, had no effect on the bang sensitivity of tko(25t) adults, and continued expression in adults older than 30 d also produced no amelioration of the phenotype. In contrast, transgenic expression of the yeast alternative NADH dehydrogenase Ndi1 was synthetically semi-lethal with tko(25t) and was lethal when combined with both AOX and tko(25t). We conclude that AOX does not rescue tko(25t) and that the mutant phenotype is not solely due to limitations on electron flow in the respiratory chain, but rather to a more complex metabolic defect. The future therapeutic use of AOX in disorders of mitochondrial translation may thus be of limited value.
AuthorsKia K Kemppainen, Esko Kemppainen, Howard T Jacobs
JournalG3 (Bethesda, Md.) (G3 (Bethesda)) Vol. 4 Issue 10 Pg. 2013-21 (Aug 21 2014) ISSN: 2160-1836 [Electronic] England
PMID25147191 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2014 Kemppainen et al.
Chemical References
  • Drosophila Proteins
  • Hormone Antagonists
  • Mitochondrial Proteins
  • Plant Proteins
  • Reactive Oxygen Species
  • Ribosomal Proteins
  • mitochondrial ribosomal protein S12
  • beta Carotene
  • Mifepristone
  • Adenosine Triphosphate
  • Oxidoreductases
  • alternative oxidase
  • NADH Dehydrogenase
  • Electron Transport Complex I
  • citroxanthin
Topics
  • Adenosine Triphosphate (pharmacology)
  • Animals
  • Ciona intestinalis (enzymology)
  • Drosophila (enzymology, genetics, growth & development, metabolism)
  • Drosophila Proteins (deficiency, genetics, metabolism)
  • Electron Transport Complex I (genetics, metabolism)
  • Embryonic Development (drug effects)
  • Female
  • Genotype
  • Hormone Antagonists (pharmacology)
  • Male
  • Mifepristone (pharmacology)
  • Mitochondria (metabolism)
  • Mitochondrial Proteins (deficiency, genetics, metabolism)
  • NADH Dehydrogenase (genetics, metabolism)
  • Oxidoreductases (genetics, metabolism)
  • Phenotype
  • Plant Proteins (genetics, metabolism)
  • Reactive Oxygen Species (metabolism)
  • Ribosomal Proteins (deficiency, genetics, metabolism)
  • beta Carotene (analogs & derivatives)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: